The company was formerly known as Shanghai Liji Biotechnology Co., Ltd., established in 2015. Heyuan Liji was jointly established by Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology in 2023. It is a domestic biological reagent company that integrates research and development, production, and sales. It focuses on the fields of life sciences and biotechnology, and is committed to providing customers with technically excellent, convenient, easy-to-use, and economically efficient products. The product range includes experimental reagents and reagent kits related to cell biology, molecular biology, immunology, and biochemistry. Currently, authorized agents are available in over 40 cities across the country; There are over a thousand direct service terminals, covering CROs, pharmaceutical companies, universities, hospitals, and research institutes; Li Ji's products have helped clients publish hundreds of SCI papers and multiple CNS papers。 Advantageous products: Protein Marker, EZ Trans Cell Transfection Reagent, CCK-8, Mycoplasma Rapid Detection Kit, Nucleic Acid Dyes (GelRed/GelGreen), EZ Protein any KD PAGE Protein Electrophoresis Kit, Fluorescent Dyes (Alexa Fluor 488, 555, 647, CY3, cy5), Fetal Bovine Serum, Cell Apoptosis Detection Kit, etc。
Company Address: 4th Floor, Building 27, Lane 908, Ziping Road, Pudong New Area International Medical Park, Shanghai
Contact email:lsj0027@obiosh.com
Landline phone number:021-50778506
service manager:18616108315